Park National Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-14,048
Closed -$266K 379
2017
Q4
$266K Sell
14,048
-3,762
-21% -$71.2K 0.01% 291
2017
Q3
$314K Buy
17,810
+1,008
+6% +$17.8K 0.02% 252
2017
Q2
$559K Sell
16,802
-1,312
-7% -$43.7K 0.03% 190
2017
Q1
$582K Buy
18,114
+1,265
+8% +$40.6K 0.04% 182
2016
Q4
$611K Buy
16,849
+376
+2% +$13.6K 0.04% 176
2016
Q3
$758K Sell
16,473
-1,432
-8% -$65.9K 0.05% 166
2016
Q2
$899K Sell
17,905
-1,048
-6% -$52.6K 0.06% 153
2016
Q1
$1.01M Sell
18,953
-1,155
-6% -$61.8K 0.07% 144
2015
Q4
$1.32M Sell
20,108
-543
-3% -$35.6K 0.09% 123
2015
Q3
$1.17M Sell
20,651
-14
-0.1% -$790 0.08% 124
2015
Q2
$1.22M Sell
20,665
-430
-2% -$25.4K 0.08% 129
2015
Q1
$1.31M Sell
21,095
-433
-2% -$27K 0.09% 124
2014
Q4
$1.24M Buy
21,528
+19
+0.1% +$1.09K 0.08% 128
2014
Q3
$1.16M Sell
21,509
-174
-0.8% -$9.35K 0.08% 124
2014
Q2
$1.14M Sell
21,683
-120
-0.6% -$6.29K 0.08% 126
2014
Q1
$1.15M Sell
21,803
-196
-0.9% -$10.4K 0.08% 127
2013
Q4
$882K Buy
21,999
+910
+4% +$36.5K 0.06% 144
2013
Q3
$797K Sell
21,089
-4,332
-17% -$164K 0.06% 151
2013
Q2
$997K Buy
+25,421
New +$997K 0.08% 131